These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B. Life Sci; 1995 Aug; 56(11-12):853-9. PubMed ID: 10188785 [Abstract] [Full Text] [Related]
5. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Saberi F, O'Donnell DE. Treat Respir Med; 2005 Aug; 4(4):275-81. PubMed ID: 16086600 [Abstract] [Full Text] [Related]
10. The future for tiotropium. Calverley PM. Chest; 2000 Feb; 117(2 Suppl):67S-9S. PubMed ID: 10673479 [Abstract] [Full Text] [Related]
11. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator]. Izquierdo Alonso JL. An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035 [Abstract] [Full Text] [Related]
19. [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment]. Ohmura T, Nishikawa H. Nihon Yakurigaku Zasshi; 2005 May; 125(5):307-13. PubMed ID: 15997169 [No Abstract] [Full Text] [Related]
20. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence. Salpeter SR. Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824 [Abstract] [Full Text] [Related] Page: [Next] [New Search]